Cancer Registry Resources

The cancer registry resources listed below provide information about sources of national and statewide cancer statistics.

  • Surveillance, Epidemiology, and End Results (SEER) Program
    The National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Program collects information on cancer incidence, prevalence, and survival from specific geographic areas representing 34% of the U.S. population and reports on all of these plus cancer mortality for the entire country.
  • SEER-Medicare Linked Database
    Data for this database come from the SEER Program of cancer registries that collects clinical, demographic, and cause of death information for persons with cancer, and from Medicare claims for covered health care services from the time of a person's Medicare eligibility until death.
  • The National Childhood Cancer Registry (NCCR)
    The primary goal of this rapidly growing public health surveillance data resource is to provide a platform to better understand the causes, outcomes, effective treatments, and later effects of cancer among children, adolescents, and young adults in the U.S.
  • National Program of Cancer Registries
    The Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries (NPCR) provides support for states and territories to maintain registries that provide high-quality data. The Web site includes cancer statistics and an online query system for cancer incidence data. NPCR supports statewide, population-based cancer registries in 46 states, the District of Columbia, Puerto Rico, the U.S. Pacific Island Jurisdictions, and the U.S. Virgin Islands.
  • Virtual Pooled Registry Cancer Linkage SystemExternal Web Site Policy
    The Virtual Pooled Registry Cancer Linkage System (VPR-CLS) is designed to connect researchers performing minimal risk linkage studies with multiple U.S. population-based cancer registries. The VPR-CLS is coordinated by the North American Association of Central Cancer Registries (NAACCR) with funding from NCI.